Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 55.08

-2.9%

Dec 26 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: sim1 who wrote (1411)	8/7/2000 4:27:28 PM
From: Biomaven	Read Replies (1) of 52153

I used to own both QTRN and MCDE a while back. I'm still tempted by QTRN - logically they should do well, but in practice they haven't. I still own NTII, which was weak today, as well as part of some SKYE that I got from the DEPO deal. I'm going to be remain patient on these for now. Other stocks in this category that I own include CDIC, CLTR and GZMO, all of which I'm hanging onto for now. It's very hard to know when one should be bottom-fishing. Lots of old, dead dogs down there that will just stay and rot. Rick generally does this better than anyone I know. He's also willing to do it in size, whereas I tend to be much too chicken to do anything more than dip my toe in the water. In the next post I'll show the biotechs and pharmas sorted by % in yearly range. Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next